Gaining clients is very expensive and losing them just because they are unresponsive is wasteful and painful. Don’t let them slip through your hands!
Our job is to locate your unresponsive clients and make sure you get the most return on your investment. We will locate your clients to:
1. Sign your firm’s retainers.
2. Locate non-responsive clients
3. Have them sign the release on settlements.
Here is one of many examples of us demonstrating our expertise:
Yaz and Yasmin are birth control pills manufactured by Bayer AG. From 2009-2019, women who took Yaz and Yasmin suffered from heart attacks, gallbladder disorders, and blood clots. Federal multidistrict litigation closed in January 2019.
A woman received a $240K settlement offer but was completely unresponsive; to receive her settlement, she needed to sign the release. We learned that her husband was in the military and he, too, was unresponsive, and she was too distraught about him to deal with any other issues. We enlisted the client’s sister—who was are of the complex situation—to help us. Her sister called us, and we sent a notary with the documents to the client while the client and her sister were at a little league game, and she finally signed the release.
Do you need a client to sign a release on a settlement, but can’t find them? We can help locate them in even the most challenging circumstances.
Need help locating your non-responsive clients?
Gaining clients is very expensive and losing them just because they are unresponsive is wasteful and painful. Don’t let them slip through your hands!
Our job is to locate your unresponsive clients and make sure you get the most return on your investment. We will locate your clients to:
1. Sign your firm’s retainers.
2. Locate non-responsive clients
3. Have them sign the release on settlements.
Here is one of many examples of us locating a non-responsive client:
Actos (pioglitazone) was previously the best-selling Type 2 Diabetes drug. However, several scientific studies revealed that patients who took Actos had a far higher rate of bladder cancer than patients on other diabetic glucose control medications. In 2015, Takeda Pharmaceuticals settled roughly 9,000 claims for $2.4 billion.
Our client, a law firm, was in the process of compiling all the medical records for the case, but they had additional questions for one of their clients. They were unable to contact the respondent—the respondent never returned their calls or answer their multiple letters.
We found out that the respondent had a heart attack and was too sick to take care of herself. One of the respondent’s daughters picked the respondent up from the hospital and took the client to her home to take care of her. We found the daughter’s name, home address, and phone number. We were able to get the daughter in touch with the law firm and confirm the necessary paperwork and signatures back to our client.
There are many instances where people move around during a settlement. We are experts in locating them.
We go through lengths to do our job.
And our job is to locate your unresponsive clients and make sure you get the most return on your investment. We will locate your clients to:
1. Sign your firm’s retainers
2. Locate non-responsive clients
3. Have them sign the release on settlements.
We help find even the hardest clients. Here is one example from the 2014 NuvaRing Lawsuit:
NuvaRing Lawsuit:
In 2014, Merck & Co. agreed to settle all claims over its hormone-infused NuvaRing birth control implant. Nearly 2,0000 lawsuits alleged that the product caused series injuries and deaths from blood clots, heart attacks, and strokes.
A woman, Jane, tried to call the firm representing her several months ago and told them she would sign the retainer, but she never sent it. CMTAS found out that she and her husband were evicted from their apartment and living with a stepsister. Their phones were disconnected due to lack of payment, and since several creditors were looking for them, they refused to answer any unknown number.
We finally obtained their cell number, but Jane continued to be unresponsive. She agreed to a date and time after we texted her. When she called us, she explained that, like many NuvaRing patients, her baby died because a blot clot developed in the placenta due to the NuvaRing.
Jane and her husband were having a difficult time coping with the tragedy and they did not want to even say the word “NuvaRing”, let alone deal with a lawsuit that reminded them of it every day. When we explained that her story could help future patients and avoid her tragedy by forcing the pharmaceutical company to warn people, she asked us to call her husband and convince him. After calling her husband and convincing him, they finally decided to sign.
This story is one of many stories we experienced when working in this case; however, we are experts in finding unresponsive clients. Whether you are looking for clients to sign a retainer, complete case settlements, or obtain proof of injury, we can help.
Rival Drug Companies Team Up for COVID-19 Vaccines
Some of the world’s biggest drugmakers are joining forces with rivals to help produce Covid-19 vaccines, forging unusual alliances that promise to substantially increase supplies by this summer.
Normally big pharmaceutical companies compete to sell cancer, arthritis and other drugs. The desperate need for Covid-19 vaccines, however, is turning fierce industry competitors into fast pandemic friends.
Read more:
Novavax Nears COVID-19 Game Changer–After Years of Failure
We find your missing clients and obtain their signatures.
Today, Novavax is advancing toward authorization of a Covid-19 vaccine. Scientists believe that, if cleared, it could be one of the more powerful weapons against the pandemic, offering key possible advantages over its competitors. Some early data suggest the Novavax shot may be one of the first shown to stem asymptomatic spread of the coronavirus and also potentially provide longer-lasting protection.
J&J RESERVES $4B FOR TALC VERDICT, EXPENSES.
We find your missing clients and obtain their signatures.
Johnson & Johnson said in a securities filing Monday that it had set aside nearly $4 billion in 2020 to cover talc settlements and a $2.1 billion verdict in favor of women who claimed its talc products caused cancer, which the company is currently appealing to the U.S. Supreme Court.
J&J is currently seeking the high court’s review of the estimated $2.1 billion verdict. In June, the Missouri Court of Appeals trimmed a 2018 $4.7 billion verdict in favor of 22 women who claimed that J&J’s baby powder caused their ovarian cancer; the court later passed on taking another look at its ruling and the state high court also refused to review the ruling.
J&J now faces 25,000 cases over its talc products, and the number of personal injury cases over its baby powder products continues to grow.
Most of the cases are pending in multidistrict litigation in New Jersey federal court. Lawsuits have also been filed in New Jersey, Missouri and California state courts.
link: https://www.law360.com/productliability/articles/1358015/j-j-reserves-4b-for-talc-verdict-expenses
Parents Face Damages Hurdle In Tainted Baby Food Suits – Law360
As lawsuits mount against makers of baby food following the release of a congressional report that showed high levels of heavy metals in such products, understandably concerned parents still have the difficult task of showing damages tied to the toxins.